Background: Coagulase negative Staphylococci (CoNS) positive blood cultures represent a complex and common challenge in clinical medicine. CoNS are common in skin flora and are often mistaken as contamination. Conversely, CoNS can also be implicated in severe and life-threatening bacteremia requiring prompt treatment. A gray area in terms of treatment approach exists for health care providers. The primary aim of this study was to examine predictive factors in patients who have positive CoNS blood cultures that met the CDC case definition of a laboratory confirmed bloodstream infection (LCBI-II) that were subsequently found to have clinically significant true bacteremia. Methods: A retrospective cohort of 288 patients that had at least two separate blood cultures positive for a coagulase negative Staphylococci between November 1st, 2017, and November 1st, 2018, were examined to determine if there were any patient specific factors that would indicate a true bacteremia with CoNS. Results: Retrospective regression analysis demonstrated that those subjected to antibiotics for two days or more (OR = 3.01), those subjected to antibiotics for seven days or more (OR = 2.86), and patients with central access (OR = 4.06) were more likely to have a true infection. Although not statistically significant, an association was also found in immunosuppressed patients (OR = 1.65), and in patients with implanted hardware (OR = 1.16). Conclusion: Patients receiving antibiotics for greater than two days and patients with a central line were more likely to have a true bloodstream infection with coagulase negative Staphylococci.
References
[1]
Centers for Disease Control and Prevention (2023) Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line-Associated Blood-Stream Infection).
[2]
Becker, K., Heilmann, C. and Peters, G. (2014) Coagulase-Negative Staphylococci. Clinical Microbiology Reviews, 27, 870-926. https://doi.org/10.1128/cmr.00109-13
[3]
Argemi, X., Hansmann, Y., Prola, K. and Prévost, G. (2019) Coagulase-Negative Staphylococci Pathogenomics. International Journal of Molecular Sciences, 20, Article No. 1215. https://doi.org/10.3390/ijms20051215
[4]
Heilmann, C., Ziebuhr, W. and Becker, K. (2019) Are Coagulase-Negative Staphylococci Virulent? Clinical Microbiology and Infection, 25, 1071-1080. https://doi.org/10.1016/j.cmi.2018.11.012
[5]
Park, S.Y., Kwon, K.H., Chung, J., Huh, H.J. and Chae, S.L. (2015) Coagulase-Negative Staphylococcal Bacteremia: Risk Factors for Mortality and Impact of Initial Appropriate Antimicrobial Therapy on Outcome. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1395-1401. https://doi.org/10.1007/s10096-015-2364-3
[6]
García-Vázquez, E., Fernández-Rufete, A., Hernández-Torres, A., Canteras, M., Ruiz, J. and Gómez, J. (2013) When Is Coagulase-Negative Staphylococcus Bacteraemia Clinically Significant? Scandinavian Journal of Infectious Diseases, 45, 664-671. https://doi.org/10.3109/00365548.2013.797599
[7]
Benjamin, D.K., Miller, W., Garges, H., Benjamin, D.K., McKinney, R.E., Cotton, M., et al. (2001) Bacteremia, Central Catheters, and Neonates: When to Pull the Line. Pediatrics, 107, 1272-1276. https://doi.org/10.1542/peds.107.6.1272
[8]
Pichitchaipitak, O., Ckumdee, S., Apivanich, S., Chotiprasitsakul, D. and Shantavasinkul, P.C. (2018) Predictive Factors of Catheter-Related Bloodstream Infection in Patients Receiving Home Parenteral Nutrition. Nutrition, 46, 1-6. https://doi.org/10.1016/j.nut.2017.08.002
[9]
Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P. and Edmond, M.B. (2004) Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study. Clinical Infectious Diseases, 39, 309-317. https://doi.org/10.1086/421946
[10]
Hall, K.K. and Lyman, J.A. (2006) Updated Review of Blood Culture Contamination. Clinical Microbiology Reviews, 19, 788-802. https://doi.org/10.1128/cmr.00062-05
[11]
Karakullukçu, A., Kuşkucu, M.A., Ergin, S., Aygün, G., Midilli, K. and Küçükbasmaci, Ö. (2017) Determination of Clinical Significance of Coagulase-Negative Staphylococci in Blood Cultures. Diagnostic Microbiology and Infectious Disease, 87, 291-294. https://doi.org/10.1016/j.diagmicrobio.2016.12.006
[12]
Rahkonen, M., Luttinen, S., Koskela, M. and Hautala, T. (2012) True Bacteremias Caused by Coagulase Negative Staphylococcus Are Difficult to Distinguish from Blood Culture Contaminants. European Journal of Clinical Microbiology & Infectious Diseases, 31, 2639-2644. https://doi.org/10.1007/s10096-012-1607-9
[13]
Hitzenbichler, F., Simon, M., Salzberger, B. and Hanses, F. (2016) Clinical Significance of Coagulase-Negative Staphylococci Other than S. Epidermidis Blood Stream Isolates at a Tertiary Care Hospital. Infection, 45, 179-186. https://doi.org/10.1007/s15010-016-0945-4
[14]
Beekmann, S.E., Diekema, D.J. and Doern, G.V. (2005) Determining the Clinical Significance of Coagulase-Negative Staphylococci Isolated from Blood Cultures. Infection Control & Hospital Epidemiology, 26, 559-566. https://doi.org/10.1086/502584
[15]
Morad Asaad, A., Ansar Qureshi, M. and Mujeeb Hasan, S. (2015) Clinical Significance of Coagulase-Negative Staphylococci Isolates from Nosocomial Bloodstream Infections. Infectious Diseases, 48, 356-360. https://doi.org/10.3109/23744235.2015.1122833
[16]
Nair, A., Elliott, S.P. and Al Mohajer, M. (2017) Knowledge, Attitude, and Practice of Blood Culture Contamination: A Multicenter Study. American Journal of Infection Control, 45, 547-548. https://doi.org/10.1016/j.ajic.2017.01.008
[17]
Tsai, H., Huang, L., Chang, L., Lee, P., Chen, J., Shao, P., et al. (2015) Central Venous Catheter-Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients and Effectiveness of Antimicrobial Lock Therapy. Journal of Microbiology, Immunology and Infection, 48, 639-646. https://doi.org/10.1016/j.jmii.2014.07.008
[18]
Centers for Disease Prevention and Control (2019) The Core Elements of Hospital Antibiotic Stewardship Programs.
[19]
Pitiriga, V., Bakalis, J., Kampos, E., Kanellopoulos, P., Saroglou, G. and Tsakris, A. (2022) Duration of Central Venous Catheter Placement and Central Line-Associated Bloodstream Infections after the Adoption of Prevention Bundles: A Two-Year Retrospective Study. Antimicrobial Resistance & Infection Control, 11, Article No. 96. https://doi.org/10.1186/s13756-022-01131-w
[20]
Ziegler, M.J., Pellegrini, D.C. and Safdar, N. (2014) Attributable Mortality of Central Line Associated Bloodstream Infection: Systematic Review and Meta-Analysis. Infection, 43, 29-36. https://doi.org/10.1007/s15010-014-0689-y
[21]
Ajenjo, M.C., Morley, J.C., Russo, A.J., McMullen, K.M., Robinson, C., Williams, R.C., et al. (2011) Peripherally Inserted Central Venous Catheter-Associated Bloodstream Infections in Hospitalized Adult Patients. Infection Control & Hospital Epidemiology, 32, 125-130. https://doi.org/10.1086/657942
[22]
Stevens, V., Geiger, K., Concannon, C., Nelson, R.E., Brown, J. and Dumyati, G. (2014) Inpatient Costs, Mortality and 30-Day Re-Admission in Patients with Central-Line-Associated Bloodstream Infections. Clinical Microbiology and Infection, 20, O318-O324. https://doi.org/10.1111/1469-0691.12407
[23]
Pitiriga, V., Kanellopoulos, P., Bakalis, I., Kampos, E., Sagris, I., Saroglou, G., et al. (2020) Central Venous Catheter-Related Bloodstream Infection and Colonization: The Impact of Insertion Site and Distribution of Multidrug-Resistant Pathogens. Antimicrobial Resistance & Infection Control, 9, Article No. 189. https://doi.org/10.1186/s13756-020-00851-1
[24]
Pepin, C.S., Thom, K.A., Sorkin, J.D., Leekha, S., Masnick, M., Preas, M.A., et al. (2015) Risk Factors for Central-Line-Associated Bloodstream Infections: A Focus on Comorbid Conditions. Infection Control & Hospital Epidemiology, 36, 479-481. https://doi.org/10.1017/ice.2014.81
